These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11604477)

  • 1. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy.
    Kanwar JR; Shen WP; Kanwar RK; Berg RW; Krissansen GW
    J Natl Cancer Inst; 2001 Oct; 93(20):1541-52. PubMed ID: 11604477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses.
    Runyon K; Lee K; Zuberek K; Collins M; Leonard JP; Dunussi-Joannopoulos K
    Blood; 2001 Apr; 97(8):2420-6. PubMed ID: 11290606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse B7-H3 induces antitumor immunity.
    Sun X; Vale M; Leung E; Kanwar JR; Gupta R; Krissansen GW
    Gene Ther; 2003 Sep; 10(20):1728-34. PubMed ID: 12939639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reassessment of the role of B7-1 expression in tumor rejection.
    Wu TC; Huang AY; Jaffee EM; Levitsky HI; Pardoll DM
    J Exp Med; 1995 Nov; 182(5):1415-21. PubMed ID: 7595212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
    Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
    J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.
    Ansell SM; Arendt BK; Grote DM; Jelinek DF; Novak AJ; Wellik LE; Remstein ED; Bennett CF; Fielding A
    Leukemia; 2004 Mar; 18(3):616-23. PubMed ID: 14749704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
    Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
    Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense HIF-1alpha prevents acquired tumor resistance to angiostatin gene therapy.
    Sun X; Vale M; Jiang X; Gupta R; Krissansen GW
    Cancer Gene Ther; 2010 Aug; 17(8):532-40. PubMed ID: 20348876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antisense hypoxia inducible factor-1alpha and B7-1 combination gene therapy for mouse lymphoma].
    Sun XY; Meng FQ; Jiang HC; Qiao HQ; Li W
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):404-7. PubMed ID: 16188124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cancer-specific gene expression by the survivin promoter.
    Bao R; Connolly DC; Murphy M; Green J; Weinstein JK; Pisarcik DA; Hamilton TC
    J Natl Cancer Inst; 2002 Apr; 94(7):522-8. PubMed ID: 11929953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
    Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
    Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
    Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.
    Li M; Xie Y; Zhang J; Zhou X; Gao L; He M; Liu X; Miao X; Liu Y; Cao R; Jia Y; Zeng Z; Liu L
    Cancer Lett; 2024 Aug; 598():217111. PubMed ID: 38972347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells.
    Zheng SY; Li DC; Zhang ZD; Zhao J; Ge JF
    World J Gastroenterol; 2005 Jun; 11(21):3204-11. PubMed ID: 15929168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1alpha.
    Sun X; Kanwar JR; Leung E; Vale M; Krissansen GW
    Gene Ther; 2003 Dec; 10(25):2081-9. PubMed ID: 14595381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aged mice develop protective antitumor immune responses with appropriate costimulation.
    Lustgarten J; Dominguez AL; Thoman M
    J Immunol; 2004 Oct; 173(7):4510-5. PubMed ID: 15383582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
    Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
    J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer gene therapy using a survivin mutant adenovirus.
    Mesri M; Wall NR; Li J; Kim RW; Altieri DC
    J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.